Parathyroid Hormone is Negatively Correlated with Glycated Hemoglobin in Newly Diagnosed Type 2 Diabetic Patients

Table 3

Spearman correlation analysis between PTH and other parameters in the newly diagnosed T2D patients.

Parameters	PTH
	r
Age (years)	−0.024	0.632
BMI (kg/m^2)	0.166	0.001
Ca (mmol/L)	−0.179	<0.001
P (mmol/L)	−0.180	<0.001
25-OH-D3 (ng/mL)	−0.246	<0.001
TC (mmol/L)	−0.067	0.190
LDL-C (mmol/L)	−0.045	0.376
HDL-C (mmol/L)	0.019	0.706
TG (mmol/L)	0.002	0.965
FFA (mmol/L)	0.095	0.064
Crea (μmol/L)	−0.003	0.959
HbA1c (%)	−0.150	0.003
FBG (mmol/L)	−0.040	0.445
FINS (μIU/mL)	0.129	0.012
HOMA-β	0.163	0.002
HOMA-IR	0.158	0.003

PTH, parathyroid hormone; BMI, body mass index; Ca, blood calcium; P, blood phosphorus; 25-OH-D3, 25-hydroxyvitamin D3; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; FFA, free fatty acids; Crea, creatinine; HbA1c, glycated hemoglobin; FBG, fasting blood glucose; FINS, fasting plasma insulin; HOMA-β, homeostasis model assessment of β-cell function; HOMA-IR, homeostasis model assessment of insulin resistance.